Tandem Diabetes (NASDAQ:TNDM) Beats Expectations in Strong Q3, Stock Jumps 17.5% [Yahoo! Finance]
Tandem Diabetes Care, Inc. (TNDM)
Last tandem diabetes care, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.tandemdiabetes.com
Company Research
Source: Yahoo! Finance
Its GAAP loss of $0.31 per share was 3.6% above analysts' consensus estimates. Is now the time to buy Tandem Diabetes? Find out in our full research report Tandem Diabetes (TNDM) Q3 CY2025 Highlights: Revenue: $249.3 million vs analyst estimates of $236 million (2.2% year-on-year growth, 5.6% beat) EPS (GAAP): -$0.31 vs analyst estimates of -$0.32 (3.6% beat) Operating Margin: -9.2%, up from -10.7% in the same quarter last year Sales Volumes fell 4.8% year on year (24.7% in the same quarter last year) Market Capitalization: $991.2 million Company Overview With technology that automatically adjusts insulin delivery based on continuous glucose monitoring data, Tandem Diabetes Care (NASDAQ:TNDM) develops and manufactures automated insulin delivery systems that help people with diabetes manage their blood glucose levels. Revenue Growth Examining a company's long-term performance can provide clues about its quality. Any business can experience short-term success, but
Show less
Read more
Impact Snapshot
Event Time:
TNDM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TNDM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TNDM alerts
High impacting Tandem Diabetes Care, Inc. news events
Weekly update
A roundup of the hottest topics
TNDM
News
- Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDMPR Newswire
- Rosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDMPR Newswire
- Tandem Diabetes (TNDM) Stock Is Up, What You Need To Know [Yahoo! Finance]Yahoo! Finance
- Tandem Diabetes Care (NASDAQ:TNDM) was given a new $23.00 price target on by analysts at Morgan Stanley.MarketBeat
- TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire
TNDM
Earnings
- 11/6/25 - In-Line
TNDM
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 3
- 11/19/25 - Form 4
- TNDM's page on the SEC website